Portfolio acquisition assurance
Review transaction information and selected supporting files. Identify inconsistencies and evidence gaps that warrant closer examination before an acquisition decision.

Understanding the true quality of a claims portfolio requires more than reviewing reported performance. Insyte IQ independently assesses the underlying data, supporting evidence and operational processes to identify potential risks, challenge assumptions and provide a clearer picture of portfolio quality and performance. Whether considering an acquisition, deploying capital or reviewing an existing portfolio, our work provides the insight needed to make informed decisions.
A transaction brings together assumptions, reported information and operational dependencies. We examine the agreed evidence and highlight matters that need further investigation.
Align audit questions with supporting documentation, including funding agreements.
Connect portfolio data, sampled files and operational observations.
Explain inconsistencies, gaps and limitations in the context of the agreed review.
Review transaction information and selected supporting files. Identify inconsistencies and evidence gaps that warrant closer examination before an acquisition decision.
Examine the processes, controls, systems and capacity supporting delivery. Identify dependencies and where reported progress needs further substantiation.
Agree a selection approach suited to the review questions, with coverage and limitations made clear in the reporting.
Where included in scope, use site visits, staff discussions and process walkthroughs to examine how documented arrangements operate in practice.
Outputs are shaped around the questions, scope and reporting arrangements agreed for the engagement.
Findings support the client’s assessment. The review scope does not automatically include legal merits, valuation or an investment recommendation.
Bring assurance, ongoing oversight, data intelligence and settlement review together around your mandate.
Tell us what you need to understand. We can discuss the scope, evidence and reporting your portfolio requires.